Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Immunohistochemistry × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Colorectal Neoplasms 2 Tongue Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Ependymoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡